Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
12.05.2025 07:00:00

Clariant rejects Dow Europe’s allegations against four companies related to the 2020 competition law infringement

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR


Muttenz, 12 May 2025

Clariant, a sustainability-focused specialty chemical company, today announced that on 9 May 2025, the company received a claim for damages against four companies, including Clariant, from Dow Europe with the court of Munich, Germany. The claim alleges damages totaling to around EUR 767 million in relation to infringement of competition law on the ethylene purchasing market which was sanctioned by the European Commission in July 2020. Clariant firmly rejects the allegation and will adamantly defend its position in the proceedings. Dow Europe was not a supplier of ethylene to Clariant and Clariant has substantiated economic evidence that the conduct of the parties did not produce any effect on the market.


 

CORPORATE MEDIA RELATIONS


 

Jochen Dubiel
Phone +41 61 469 63 63
jochen.dubiel@clariant.com


 

Ellese Caruana
Phone +41 61 469 63 63
ellese.caruana@clariant.com


 

Luca Lavina
Phone +41 61 469 63 63
luca.lavina@clariant.com


 


 

Follow us on X, Facebook, LinkedIn, Instagram.

 

INVESTOR RELATIONS


 

Andreas Schwarzwälder
Phone +41 61 469 63 73
andreas.schwarzwaelder@clariant.com


 

Thijs Bouwens
Phone +41 61 469 63 73
thijs.bouwens@clariant.com


 


 


 


 


 


 

 

This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, Inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.


 

www.clariant.com


 

Clariant is a focused specialty chemical company led by the overarching purpose of ‘Greater chemistry – between people and planet’. By connecting customer focus, innovation, and people the company creates solutions to foster sustainability in different industries. On 31 December 2023, Clariant totaled a staff number of 10 481 and recorded sales of CHF 4.377 billion in the fiscal year for its continuing businesses. As of January 2023, the Group conducts its business through the three Business Units Care Chemicals, Catalysts, and Adsorbents & Additives. Clariant is based in Switzerland.

Attachment


Analysen zu Clariant AG (N)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Unbekannte Renditechampions? – Daniel Riediker zu Gast im BX Morningcall mit François Bloch

Strukturierte Kredite – hohe Rendite bei geringerem Risiko? Daniel Riediker, CEO & Mitgründer von Alegra Capital, erklärt im BX Morning Call, warum CLOs (Collateralized Loan Obligations) zu den spannendsten, aber am wenigsten verstandenen Investments gehören – und wie seine Fonds Krisen wie die Finanzkrise und Covid meistern konnten.

Im aktuellen BX Morning Call sprechen François Bloch und Olivia Hähnel (BX Swiss) mit Daniel Riediker, CEO und Mitgründer von Alegra Capital, einem der führenden europäischen Experten im Bereich strukturierter Kreditverbriefungen.

Seit 2003 ist Alegra Capital auf CLOs (Collateralized Loan Obligations) spezialisiert – ein komplexes, aber oft unterschätztes Anlageinstrument mit beeindruckender Performance und klarer Strategie. Im Gespräch gewährt Daniel Riediker exklusive Einblicke in die Welt der CLOs, spricht offen über Herausforderungen während der Finanzkrise, seine Investmentphilosophie und erklärt, warum seine Fonds seit Jahren zu den leistungsstärksten Alternativen im Fixed-Income-Bereich zählen.

👉🏽 https://bxplus.ch/bx-musterportfolio/

Unbekannte Renditechampions? – Daniel Riediker zu Gast im BX Morningcall mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’673.20 17.89 BC8S1U
Short 12’936.00 13.50 SS4MTU
Short 13’406.08 8.81 BDGS0U
SMI-Kurs: 12’132.19 14.05.2025 17:30:33
Long 11’728.85 19.68 BQUSIU
Long 11’432.78 13.19 BXGS2U
Long 10’985.53 8.85 BAOSEU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}